In the past week, GUTS stock has gone down by -22.86%, with a monthly decline of -27.93% and a quarterly plunge of -45.47%. The volatility ratio for the week is 10.25%, and the volatility levels for the last 30 days are 8.60% for Fractyl Health Inc The simple moving average for the past 20 days is -19.03% for GUTS’s stock, with a -56.97% simple moving average for the past 200 days.
Is It Worth Investing in Fractyl Health Inc (NASDAQ: GUTS) Right Now?
The stock has a 36-month beta value of -0.49. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GUTS is 20.64M, and at present, short sellers hold a 13.21% of that float. On February 05, 2025, the average trading volume of GUTS was 357.85K shares.
GUTS) stock’s latest price update
The stock of Fractyl Health Inc (NASDAQ: GUTS) has decreased by -9.71 when compared to last closing price of 1.70.Despite this, the company has seen a loss of -22.86% in its stock price over the last five trading days. globenewswire.com reported 2025-01-31 that Prioritizing Revita’s clinical development on weight maintenance post-GLP-1 withdrawal in response to significant patient and physician demand in ongoing REMAIN-1 pivotal study; anticipate midpoint data analysis in Q2 2025 and full pivotal study enrollment in summer 2025
Analysts’ Opinion of GUTS
Morgan Stanley, on the other hand, stated in their research note that they expect to see GUTS reach a price target of $18. The rating they have provided for GUTS stocks is “Overweight” according to the report published on February 27th, 2024.
BofA Securities gave a rating of “Buy” to GUTS, setting the target price at $26 in the report published on February 27th of the previous year.
GUTS Trading at -25.01% from the 50-Day Moving Average
After a stumble in the market that brought GUTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.03% of loss for the given period.
Volatility was left at 8.60%, however, over the last 30 days, the volatility rate increased by 10.25%, as shares sank -30.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.14% lower at present.
During the last 5 trading sessions, GUTS fell by -23.12%, which changed the moving average for the period of 200-days by -76.96% in comparison to the 20-day moving average, which settled at $1.8955. In addition, Fractyl Health Inc saw -25.49% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GUTS starting from Rajagopalan Harith, who sale 90,972 shares at the price of $1.82 back on Jan 31 ’25. After this action, Rajagopalan Harith now owns 491,329 shares of Fractyl Health Inc, valued at $165,205 using the latest closing price.
Rajagopalan Harith, the Chief Executive Officer of Fractyl Health Inc, sale 20,948 shares at $1.95 during a trade that took place back on Jan 30 ’25, which means that Rajagopalan Harith is holding 491,329 shares at $40,798 based on the most recent closing price.
Stock Fundamentals for GUTS
Current profitability levels for the company are sitting at:
- -838.16 for the present operating margin
- -0.47 for the gross margin
The net margin for Fractyl Health Inc stands at -648.49. The total capital return value is set at -0.73.
Based on Fractyl Health Inc (GUTS), the company’s capital structure generated 0.56 points at debt to capital in total, while cash flow to debt ratio is standing at -0.94.
Currently, EBITDA for the company is -50.55 million with net debt to EBITDA at 0.27. When we switch over and look at the enterprise to sales, we see a ratio of 537.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.58.
Conclusion
To sum up, Fractyl Health Inc (GUTS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
